NCT05868733: A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa |
|
|
| Recruiting | 2 | 612 | RoW | Day 1 Lower Dose (2×106 pfu), Day 1 Higher Dose (1×107 pfu), Placebo | International AIDS Vaccine Initiative, Coalition for Epidemic Preparedness Innovations | Lassa Fever | 08/26 | 02/27 | | |